The International Psoriasis Council is pleased to welcome AnaptysBio as a 2022 Bronze Level Corporate Member. AnaptysBio, based in San Diego, California, is a clinical-stage biotechnology company developing first-in-class immunology therapeutic product candidates for patients. They are focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. “We are extremely pleased to welcome AnaptysBio to the IPC family and look forward to working with them to improve the care of people with psoriasis worldwide through education, research, and advocacy,” said IPC CEO Christy Langan.
Learn more about AnaptysBio.